Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.32 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.32 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3480188 | 0.76 | SLC1A3 (0.35) | SLC1A3SLC1A2SLC1A1DPP4DPP8 | |
| SCHEMBL10750235 | 0.76 | SLC1A3 (0.35) | SLC1A3SLC1A2SLC1A1DPP4DPP8 | |
| SCHEMBL446082 | 0.75 | ALDH1A1 (0.34) | SLC1A3SLC1A2SLC1A1DPP4DPP8 | |
| SCHEMBL6361462 | 0.72 | SLC1A3 (0.33) | SLC1A3SLC1A2SLC1A1DPP4DPP8 | |
| Methylamine SCHEMBL8735479 | 0.71 | SLC1A3 (0.32) | SLC1A3SLC1A2SLC1A1DPP4DPP8 | |
| SCHEMBL6839342 | 0.71 | SLC1A3 (0.32) | SLC1A3SLC1A2SLC1A1DPP4DPP8 | |
| SCHEMBL19908715 | 0.70 | — | — | |
| SCHEMBL15417545 | 0.70 | — | — | |
| SCHEMBL30660250 | 0.70 | — | — | |
| SCHEMBL9221700 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006052598-A2 | VINYL AMIDE-CONTAINING ADHESIVE COMPOSITIONS FOR PLASTIC BONDING, AND METHODS AND PRODUCTS UTILIZING SAME | DYMAX CORPORATION (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060100352-A1 | Vinyl amide-containing adhesive compositions for plastic bonding, and methods and products utilizing same | TD BANKNORTH, N.A. | 2006-05-11 | — | — | US | claimed |
| EP-2548900-B1 | CATIONIC NANOGELS FOR BIOTECHNOLOGICAL USES | UNIV PAIS VASCO (ES) | 2017-08-02 | — | — | EP | disclosed |
| US-20130072576-A1 | Cationic Nanogels For Biotechnological Applications | UNIVERSIDAD DEL PAIS VASCO (ES) | 2013-03-21 | — | — | US | disclosed |
| EP-2548900-A1 | CATIONIC NANOGELS FOR BIOTECHNOLOGICAL USES | Universidad del Pais Vasco (ES) | 2013-01-23 | — | — | EP | disclosed |
| WO-2006052598-A2 | VINYL AMIDE-CONTAINING ADHESIVE COMPOSITIONS FOR PLASTIC BONDING, AND METHODS AND PRODUCTS UTILIZING SAME | DYMAX CORPORATION (US) | 2006-05-18 | — | — | WO | disclosed |
| US-20060100352-A1 | Vinyl amide-containing adhesive compositions for plastic bonding, and methods and products utilizing same | TD BANKNORTH, N.A. | 2006-05-11 | — | — | US | disclosed |
| US-4212820-A | Acrylamide or methacrylamide alkoxypropyl quaternary compounds | TEXACO DEVELOPMENT CORPORATION (US) | 1980-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060100352-A1 | Vinyl amide-containing adhesive compositions for plastic bonding, and methods and products utilizing same | VCL, AAAS, VCAM1 | SLC1A3 825/4885SLC1A2 724/4885SLC1A1 829/4885 |
| US-20130072576-A1 | Cationic Nanogels For Biotechnological Applications | PUF60, PARN, NCL | SLC1A3 1966/4885SLC1A2 2752/4885SLC1A1 1785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.